Literature DB >> 12975327

Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.

John R Jalas1, Xinxin Ding, Sharon E Murphy.   

Abstract

The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its carbonyl-reduction product, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), are potent lung carcinogens in rats and are presumed human lung carcinogens. NNK and NNAL are bioactivated to DNA-binding intermediates via hydroxylation of the carbon atoms adjacent to the nitroso moiety (i.e., alpha-hydroxylation) by cytochrome p450s (p450s). Therefore, it is important to delineate which p450s are efficient catalysts of this metabolic transformation. In this study, the kinetic parameters for NNK and NNAL metabolism were determined for two extrahepatic p450s that are expressed in the lung: rat p450 2A3 and human p450 2A13. p450s 2A3 and 2A13 exhibited Vmax values for NNK 4-hydroxylation of 10.8 +/- 0.4 and 13.8 +/- 0.8 pmol min-1 pmol P450-1, respectively; the corresponding Km values were 4.6 +/- 0.5 and 3.6 +/- 0.7 microM. The respective Vmax values for p450 2A3- and 2A13-mediated N-methyl hydroxylation of NNK were 8.2 +/- 0.3 and 4.6 +/- 0.2 pmol min-1 pmol p450-1. These data indicate that p450s 2A3 and 2A13 are both efficient catalysts of the metabolic activation of NNK and are, along with mouse p450 2A5, the best catalysts of this reaction currently known. Both enzymes also catalyzed the alpha-hydroxylation and N-oxidation of NNAL, and its oxidation to NNK. In general, Vmax/Km values for NNAL metabolism were 1 to 2 orders of magnitude lower than those for NNK metabolism, and p450 2A3 was a slightly better catalyst of NNAL metabolism than was p450 2A13. Given the exquisite sensitivity of the rat lung to NNK-induced carcinogenesis, the efficient bioactivation of NNK by rat p450 2A3, and the similar catalytic efficiency of p450s 2A3 and 2A13, p450 2A13 may be an important contributor to NNK bioactivation in the human lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975327     DOI: 10.1124/dmd.31.10.1199

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  20 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

3.  Mass Spectrometric Quantitation of Pyridyloxobutyl DNA Phosphate Adducts in Rats Chronically Treated with N'-Nitrosonornicotine.

Authors:  Yupeng Li; Bin Ma; Qing Cao; Silvia Balbo; Lijiao Zhao; Pramod Upadhyaya; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2019-02-26       Impact factor: 3.739

4.  Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.

Authors:  Xin Zhou; Jaime D'Agostino; Fang Xie; Xinxin Ding
Journal:  J Pharmacol Exp Ther       Date:  2012-01-19       Impact factor: 4.030

5.  Modulation of N-nitrosomethylbenzylamine metabolism by black raspberries in the esophagus and liver of Fischer 344 rats.

Authors:  Rashmeet K Reen; Ron Nines; Gary D Stoner
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

6.  The inhibition of cytochrome P450 2A13-catalyzed NNK metabolism by NAT, NAB and nicotine.

Authors:  Xingyu Liu; Jie Zhang; Chen Zhang; Bicheng Yang; Limeng Wang; Jun Zhou
Journal:  Toxicol Res (Camb)       Date:  2016-04-28       Impact factor: 3.524

7.  Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.

Authors:  Kari E Schlicht; Jeannette Zinggeler Berg; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

8.  Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.

Authors:  Jaime D'Agostino; Xiuling Zhang; Hong Wu; Guoyu Ling; Suping Wang; Qing-Yu Zhang; Fucai Liu; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-07-31       Impact factor: 3.922

9.  Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Siyi Zhang; Mingyao Wang; Peter W Villalta; Bruce R Lindgren; Pramod Upadhyaya; Yanbin Lao; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

10.  Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS.

Authors:  Besnik Bajrami; Sadagopan Krishnan; James F Rusling
Journal:  Drug Metab Lett       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.